Avance Biosciences announced that its Houston facility was successfully inspected by the U.S. FDA on October 1 through October 4, 2018.  This inspection focused on the firm’s quality management system, operation procedures, and data integrity, as well as various analyses performed on a specific drug product from one of its clients. As a provider of biological testing services, Avance Biosciences offers a broad range of molecular biology and microbiology assays in compliance with current...